Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market Authorized Generic, Sincalide for Injection
Imaging Technology
JUNE 21, 2023
milla1cf Wed, 06/21/2023 - 19:47 June 21, 2023 — Fresenius Kabi , a leading provider of injectable medicines, announced today it has launched the diagnostic pharmaceutical agent, Sincalide for Injection, an authorized generic for Bracco Diagnostics Inc. ’s supply chain of care," said John Ducker , president and CEO of Fresenius Kabi USA.
Let's personalize your content